project id: TCGA-LUAD; case submitter id: TCGA-69-8253; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; age at index: 59; days to birth: -21771; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1953; age at diagnosis: 21771; ajcc pathologic m: MX; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T1a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 426.0; icd 10 code: C34.3; last known disease status: not reported; morphology: 8255/3; primary diagnosis: Adenocarcinoma with mixed subtypes; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower lobe, lung; synchronous malignancy: No; tissue or organ of origin: Lower lobe, lung; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; cigarettes per day: 0.4273972602739726; pack years smoked: 7.8; years smoked: 39.0; is ffpe: false; weight: 35.0; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.6; longest dimension: 1.2; oct embedded: No; shortest dimension: 0.5; portion submitter id: TCGA-69-8253-01A-11; percent necrosis: 0.0; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor cells: 85.0; percent tumor nuclei: 70.0;